TITAN BIO-TECH LTD.

NSE : NABSE : 524717ISIN CODE : INE150C01011Industry : ChemicalsHouse : Private
BSE509.20-2.7 (-0.53 %)
PREV CLOSE ( ) 511.90
OPEN PRICE ( ) 515.00
BID PRICE (QTY) 505.70 (3)
OFFER PRICE (QTY) 509.30 (20)
VOLUME 8691
TODAY'S LOW / HIGH ( )500.65 523.70
52 WK LOW / HIGH ( ) 214.05618
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax281.16289.69427.06104.0455.44
Adjustment36.9335.2041.6143.9842.12
Changes In working Capital-31.31-33.31-169.01-64.99-30.93
Cash Flow after changes in Working Capital286.78291.59299.6683.0366.63
Cash Flow from Operating Activities211.78220.41190.8261.1654.67
Cash Flow from Investing Activities-207.25-164.37-48.65-22.10-41.08
Cash Flow from Financing Activities-24.03-40.99-105.99-39.48-2.20
Net Cash Inflow / Outflow-19.5015.0536.18-0.4211.38
Opening Cash & Cash Equivalents68.1453.0918.3318.757.37
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent48.6468.1454.5118.3318.75

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.